General
12 May 2026
Clarity on the Updated Guidelines for ERA of Human Pharmaceuticals
European Medicines Agency provides Clarity on the Updated Guidelines for Environmental Risk Assessment of Human PharmaceuticalsTowards the end of 20...
12 May 2026
UK PFAS Policy: From Evidence Gathering to Potential Phase-Outs
Following the publication of the UK PFAS Plan by DEFRA in February 2026, a UK Parliamentary Committee has issued recommendations calling for the pha...
A New Chapter… and a Bigger Platform for Greater Regulatory ScienceWe’ve got some big news…Blue Frog Scientific has joined Certania – an internation...
05 May 2026
A Regulatory Framework for Assessing the Variability & Safety of Nanoforms
Rethinking Nanoform Regulation: Towards a More Proportionate, Science-Based FrameworkNanomaterials are at the heart of modern innovation – but regul...
05 May 2026
Environmental Risk Assessment of Generic Human Pharmaceuticals
Environmental Risk Assessment for Generics: Necessary Safeguard or Costly Box-Ticking?Environmental Risk Assessment (ERA) has long been part of phar...
05 May 2026
A Desk-Based Approach to Determine the New CLP Endocrine Disruption Hazard Classes
Endocrine disruption is now firmly on the regulatory agenda – and with the introduction of new hazard classes under CLP, many organisations are faci...
05 May 2026
Bioaccumulation Assessment Using New Approach Methodologies for Difficult Substances
Join Blue Frog Scientific at SETAC EU 2026: Advancing Bioaccumulation Assessment with NAMsBlue Frog Scientific will be presenting new research at SE...
28 Apr 2026
Grouping & Read-Across of Advanced (Nano)Materials Workshop
Dr Kai Benjamin Paul will be speaking at the upcoming Grouping & Read-Across of Advanced (Nano)Materials Workshop on 4 May 2026 (11:00–12:30 CET...
13 Apr 2026
Read-Across: Scientific Innovation Meets Regulatory Scrutiny
With the increasing emphasis on the 3Rs (Replacement, Reduction, & Refinement), read-across remains a central strategy for delivering scientific...
REACH Study Summaries Underpin Regulatory Decision MakingUnder EU and UK REACH, the preparation of robust study summaries is not simply an administr...